In our aging society, healing joint problems is becoming increasingly important. To do this, cartilage damage must become repairable.
Apr 12 2024University Medical Center Utrecht But so far it has proven impossible to recreate the intricate internal structure of cartilage. Professor Jos Malda has now received an ERC Advanced grant of €2.5 million to crack that code.
Cartilage is a challenging tissue due to its arched structure Cartilage contains few cells, but lots of collagen in an arcuate structure. A prestigious grant to understand cartilage The 2.5 million euros that Jos Malda is now receiving from the European Research Council, the largest individual grant in Europe, is intended to find out once and for all how these cartilage arches arise, and how we can recreate it for regenerative treatments. 'The great thing about this ERC Advanced grant is that it gives a lot of freedom.
Related StoriesAnother important phase is at the Faculty of Veterinary Medicine at Utrecht University. 'I have been collecting cartilage from joints of various mammals for over fifteen years,' Jos explains. 'It started with horses and dogs, but after I had the opportunity to examine an elephant that died in a zoo, I started looking more broadly. Now I have broad selection in the drawer, from giraffes and kangaroos to orcas and sperm whales.
Aging Collagen Medicine Research Technology Walking
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Comprehensive toolkit for advanced CAR-NK cell therapy innovationThis article outlines a detailed overview of the advancements and methodologies in CAR-NK cell therapy development.
Read more »
Man United sensation Kobbie Mainoo in advanced talks over new dealThe inside track on the football stories that matter
Read more »
Motherwell confirm advanced talks with Us investors over potential partnershipThe Steelmen are one of one only three fan owned clubs in the Premiership.
Read more »
Treatment of advanced non-small cell lung cancer with driver mutationsLung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.
Read more »
Doctor gets first US lung-liver transplant for advanced lung cancerDr. Gary Gibbon didn't have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and caused irreparable damage to his liver.
Read more »
Advanced laser imaging illuminates molecular interactions driving lung cancer growthResearchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
Read more »